133 related articles for article (PubMed ID: 11708475)
21. Genetic detection for hematogenous micrometastasis in patients with various types of malignant tumors using Uroplakin II derived primers in polymerase chain reaction.
Hirata H; Hisatomi H; Kawakita M; Nagao K; Yamamoto S; Hikiji K; Nakamoto T; Harasawa H; Kaneko N; Matsuda T; Yamamoto M; Kanamaru T
Oncol Rep; 2003; 10(4):963-6. PubMed ID: 12792753
[TBL] [Abstract][Full Text] [Related]
22. Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system.
Stathopoulou A; Gizi A; Perraki M; Apostolaki S; Malamos N; Mavroudis D; Georgoulias V; Lianidou ES
Clin Cancer Res; 2003 Nov; 9(14):5145-51. PubMed ID: 14613993
[TBL] [Abstract][Full Text] [Related]
23. The detection of circulating tumor cells of breast cancer patients by using multimarker (Survivin, hTERT and hMAM) quantitative real-time PCR.
Shen C; Hu L; Xia L; Li Y
Clin Biochem; 2009 Feb; 42(3):194-200. PubMed ID: 19022237
[TBL] [Abstract][Full Text] [Related]
24. Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes.
Sher YP; Shih JY; Yang PC; Roffler SR; Chu YW; Wu CW; Yu CL; Peck K
Clin Cancer Res; 2005 Jan; 11(1):173-9. PubMed ID: 15671543
[TBL] [Abstract][Full Text] [Related]
25. Circulating cell-free mRNA in plasma as a tumor marker for patients with primary and recurrent gastric cancer.
Tani N; Ichikawa D; Ikoma D; Tomita H; Sai S; Ikoma H; Okamoto K; Ochiai T; Ueda Y; Otsuji E; Yamagishi H; Miura N; Shiota G
Anticancer Res; 2007; 27(2):1207-12. PubMed ID: 17465264
[TBL] [Abstract][Full Text] [Related]
26. Principal component analysis, hierarchical clustering, and decision tree assessment of plasma mRNA and hormone levels as an early detection strategy for small intestinal neuroendocrine (carcinoid) tumors.
Modlin IM; Gustafsson BI; Drozdov I; Nadler B; Pfragner R; Kidd M
Ann Surg Oncol; 2009 Feb; 16(2):487-98. PubMed ID: 19050963
[TBL] [Abstract][Full Text] [Related]
27. Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection.
Pinzani P; Salvadori B; Simi L; Bianchi S; Distante V; Cataliotti L; Pazzagli M; Orlando C
Hum Pathol; 2006 Jun; 37(6):711-8. PubMed ID: 16733212
[TBL] [Abstract][Full Text] [Related]
28. Expression of progastrin-releasing peptide and gastrin-releasing peptide receptor mRNA transcripts in tumor cells of patients with small cell lung cancer.
Uchida K; Kojima A; Morokawa N; Tanabe O; Anzai C; Kawakami M; Eto Y; Yoshimura K
J Cancer Res Clin Oncol; 2002 Dec; 128(12):633-40. PubMed ID: 12474049
[TBL] [Abstract][Full Text] [Related]
29. Identification of carcinoma cells in peripheral blood samples of patients with advanced breast carcinoma using RT-PCR amplification of CK7 and MUC1.
Felton T; Harris GC; Pinder SE; Snead DR; Carter GI; Bell JA; Haines A; Kollias J; Robertson JF; Elston CW; Ellis IO
Breast; 2004 Feb; 13(1):35-41. PubMed ID: 14759714
[TBL] [Abstract][Full Text] [Related]
30. Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral blood.
Roncella S; Ferro P; Bacigalupo B; Pronzato P; Tognoni A; Falco E; Gianquinto D; Ansaldo V; Dessanti P; Fais F; Rosai J; Fedeli F
J Exp Clin Cancer Res; 2005 Jun; 24(2):265-71. PubMed ID: 16110760
[TBL] [Abstract][Full Text] [Related]
31. Search for epithelial-specific mRNAs in peripheral blood of patients with colon cancer by RT-PCR.
Solmi R; De Sanctis P; Zucchini C; Ugolini G; Rosati G; Del Governatore M; Coppola D; Yeatman TJ; Lenzi L; Caira A; Zanotti S; Taffurelli M; Carinci P; Valvassori L; Strippoli P
Int J Oncol; 2004 Oct; 25(4):1049-56. PubMed ID: 15375555
[TBL] [Abstract][Full Text] [Related]
32. [Expression and clinical significance of surfactant protein D mRNA in peripheral blood of lung cancer patients].
Qi ZL; Xiao L; Gao YT; Du JM; Jing L
Ai Zheng; 2002 Jul; 21(7):772-5. PubMed ID: 12479105
[TBL] [Abstract][Full Text] [Related]
33. Real-time PCR (TaqMan PCR) quantification of carcinoembryonic antigen (CEA) mRNA in the peripheral blood of colorectal cancer patients.
Miura M; Ichikawa Y; Tanaka K; Kamiyama M; Hamaguchi Y; Ishikawa T; Yamaguchi S; Togo S; Ike H; Ooki S; Shimada H
Anticancer Res; 2003; 23(2B):1271-6. PubMed ID: 12820382
[TBL] [Abstract][Full Text] [Related]
34. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
35. Detection of CK19, CK20 and EGFR mRNAs in peripheral blood of carcinoma patients: correlation with clinical stage of disease.
Gradilone A; Gazzaniga P; Silvestri I; Gandini O; Trasatti L; Lauro S; Frati L; Aglianò AM
Oncol Rep; 2003; 10(1):217-22. PubMed ID: 12469172
[TBL] [Abstract][Full Text] [Related]
36. The hTERT mRNA in plasma samples of early breast cancer patients, non-cancer patients and healthy individuals.
Perhavec A; Cerkovnik P; Novakovic S; Zgajnar J
Neoplasma; 2008; 55(6):549-54. PubMed ID: 18999886
[TBL] [Abstract][Full Text] [Related]
37. Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance.
Apostolaki S; Perraki M; Kallergi G; Kafousi M; Papadopoulos S; Kotsakis A; Pallis A; Xenidis N; Kalmanti L; Kalbakis K; Agelaki S; Kalykaki A; Stournaras C; Stathopoulos E; Georgoulias V; Mavroudis D
Breast Cancer Res Treat; 2009 Oct; 117(3):525-34. PubMed ID: 19016323
[TBL] [Abstract][Full Text] [Related]
38. Circulating tumor cells in breast cancer.
Ignatiadis M; Georgoulias V; Mavroudis D
Curr Opin Obstet Gynecol; 2008 Feb; 20(1):55-60. PubMed ID: 18197007
[TBL] [Abstract][Full Text] [Related]
39. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.
Hsu HS; Chen TP; Hung CH; Wen CK; Lin RK; Lee HC; Wang YC
Cancer; 2007 Nov; 110(9):2019-26. PubMed ID: 17876837
[TBL] [Abstract][Full Text] [Related]
40. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform.
Resnick KE; Alder H; Hagan JP; Richardson DL; Croce CM; Cohn DE
Gynecol Oncol; 2009 Jan; 112(1):55-9. PubMed ID: 18954897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
